Tightening trading terms to boost profits: Sigma
27th March 2014
Pharmacy wholesaler, Sigma Pharmaceuticals, hopes that tightening trading terms will deliver improvements in gross profits going forward.
In a statement to the Australian Securities Exchange (ASX), Sigma reported earnings before tax and interest had reached $70.3 million in the 2014 Financial Year – up from $23.1 million last year.
The company revealed it expects to achieve continued revenue growth above the dampening